OTC promotion committee would unlikely trigger disputes in medical community, KMPA says

Published: 2004-05-14 06:59:00

Updated: 2004-05-14 06:59:00

The Korea Pharmaceutical Manufacturers Association said recently that the business operations of a newly established OTC Promotion Committee, which was harshly criticized from local practitioners, would not undermine the intrinsic rights of doctors and pharmacists with no possible disputes betwee...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK